
Diabetes-tailored DASH Diet Lowers Key Glucose Markers in Type 2 Diabetes
A secondary analysis of the DASH4D trial in 101 adults with type 2 diabetes found that a diabetes-tailored DASH diet reduced glycemic biomarkers versus a typical US diet: fructosamine −5.6 μmol/L, fasting glucose −4.5 mg/dL, and HbA1c −0.09 percentage points, with larger fructosamine reductions in those with higher baseline HbA1c. Adherence was high and weight remained stable, with meals prepared in a metabolic kitchen. Limitations include exclusion of HbA1c >9% and small subgroup sizes. The findings suggest DASH4D could offer a practical eating framework to improve glucose control in diabetes.













